Disitamab vedotin vs. gemcitabine-cisplatin regimen with immunotherapy: a comparative analysis of efficacy and safety in muscle-invasive bladder cancer - Zhang, Chuanao; Yu, Yanhang; Zhou, Qi; Ouyang, Jun; Zhang, Zhiyu (Frontiers in Immunology, 2025)